Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
Clinical and Molecular Hepatology · 2024
DOI: 10.3350/cmh.2024.0157 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, 2024. Verfasst von Hiroyuki Suzuki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
To the editor,Patients with steatotic liver disease (SLD) linked to cardiometabolic dysregulation
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Suzuki, H., Tsutsumi, T., Kawaguchi, M., Amano, K., & Kawaguchi, T. (2024). Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0157
Vancouver
Suzuki H, Tsutsumi T, Kawaguchi M, Amano K, Kawaguchi T. Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia. Clinical and Molecular Hepatology. 2024. doi:10.3350/cmh.2024.0157
BibTeX
@article{Suzuki2024,
author = {Suzuki, Hiroyuki and Tsutsumi, Tsubasa and Kawaguchi, Machiko and Amano, Keisuke and Kawaguchi, Takumi},
title = {Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia},
journal = {Clinical and Molecular Hepatology},
year = {2024},
doi = {10.3350/cmh.2024.0157}
}
EUVIMED